SCHEMBL17429855

SCHEMBL17429855

CC(=O)C[S+]([O-])C(c1ccccc1)c1cccc(Br)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
CTSA P10619 1/20 0.38
SLC6A9 P48067 2/20 0.38
PTGES O14684 1/20 0.38
MAPT P10636 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
IDO1 P14902 1/20 0.37
TDO2 P48775 1/20 0.37
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
MAOB P27338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13197998 0.87 ALDH1A1 (0.41) ALDH1A1MAPTMTNR1AMTNR1B
SCHEMBL16011766 0.86 IDO1 (0.40) ALDH1A1CTSASLC6A9NPSR1IDO1
SCHEMBL17429841 0.83 KDM4E (0.44) ALDH1A1PTGESMAPTHTTNPSR1
SCHEMBL17432246 0.81 ALDH1A1 (0.37) ALDH1A1CTSAPTGESMAPTHTT
SCHEMBL2615349 0.78 ALDH1A1 (0.43) ALDH1A1SLC6A9MAPTHTTNPSR1
SCHEMBL2615348 0.78 ALDH1A1 (0.43) ALDH1A1SLC6A9MAPTHTTNPSR1
SCHEMBL17429838 0.78 HDAC4 (0.43) SLC6A9MAOB
SCHEMBL17429843 0.78 MEN1 (0.40) ALDH1A1NPSR1MAOB
SCHEMBL3912386 0.73 CES2 (0.41)
SCHEMBL4057742 0.73 CES2 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9862679-B2 Potent and selective inhibitors of monoamine transporters; method of making; and use thereof THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH (US) 2018-01-09 US disclosed
US-20160009644-A1 POTENT AND SELECTIVE INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF MAKING; AND USE THEREOF The United States of America, as represented by th Secretary, Department of Health and Human Service (US) 2016-01-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009644-A1 POTENT AND SELECTIVE INHIBITORS OF MONOAMINE TRANSPORTERS; METHOD OF MAKING; AND USE THEREOF SLC6A2, SLC6A4, SLC6A3 ALDH1A1 926/4885CTSA 735/4885SLC6A9 75/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.